Squamous Cell Carcinoma: An Update on Diagnosis and Treatment
Article Properties
-
DOI (url)
-
Publication Date2020/06/29
-
Indian UGC (journal)
-
Citations24
-
Andrea Combalia
-
Cristina Carrera ORCID (unauthenticated)
Abstract
Cite
Combalia, Andrea, and Cristina Carrera. “Squamous Cell Carcinoma: An Update on Diagnosis and Treatment”. Dermatology Practical &Amp; Conceptual, 2020, p. e2020066, https://doi.org/10.5826/dpc.1003a66.
Combalia, A., & Carrera, C. (2020). Squamous Cell Carcinoma: An Update on Diagnosis and Treatment. Dermatology Practical &Amp; Conceptual, e2020066. https://doi.org/10.5826/dpc.1003a66
Combalia A, Carrera C. Squamous Cell Carcinoma: An Update on Diagnosis and Treatment. Dermatology Practical & Conceptual. 2020;:e2020066.
Journal Categories
Medicine
Dermatology
Medicine
Medicine (General)
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Blue light aminolevulinic acid photodynamic therapy downregulates cell division and proliferation pathways in cutaneous squamous cell carcinoma | Journal of Biophotonics |
| 2024 | |
Shedding new light on actinic keratoses and squamous cell carcinoma in situ | JAAPA |
| 2024 | |
Management of Cutaneous Squamous Cell Carcinoma of the Scalp: The Role of Imaging and Therapeutic Approaches | Cancers |
| 2024 | |
Ultraviolet Radiation Biological and Medical Implications | Current Issues in Molecular Biology |
| 2024 | |
Dermatologic Manifestations of Mitochondrial Dysfunction: A Review of the Literature | International Journal of Molecular Sciences |
| 2024 |
Citations Analysis
The category
Medicine: Medicine (General) 12
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Cemiplimab in treatment of metastatic squamous cell carcinoma and was published in 2021. The most recent citation comes from a 2024 study titled Dermatologic Manifestations of Mitochondrial Dysfunction: A Review of the Literature. This article reached its peak citation in 2022, with 7 citations. It has been cited in 20 different journals, 25% of which are open access. Among related journals, the Cancers cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.